GRNY ETF Analysis: Fundstrat Granny Shots US | NYSE

Large Growth | NYSE, USA | Market Cap: 4.573m USD | 12M Return: 15.1% | Charts, Fundamentals & Technical Analysis

Large Cap Stocks, US Equities, Growth Stocks, Active Management
Total Rating 47
Safety 47
Buy Signal -0.22
Large Growth
Category Rotation: +14.3
TER: 0.75%
AUM: 4.57B
Avg Turnover: 30.2M
Risk 3d forecast
Volatility16.0%
VaR 5th Pctl3.09%
VaR vs Median7.28%
Reward TTM
Sharpe Ratio0.63
Rel. Str. IBD60.4
Rel. Str. Peer Group35.4
Character TTM
Beta1.326
Beta Downside1.346
Hurst Exponent0.435
Drawdowns 3y
Max DD24.18%
CAGR/Max DD0.83
CAGR/Mean DD5.53

Warnings

No concerns identified

Tailwinds

No distinct edge detected

Seasonality 1.9 years of data

Jan -0.7% -
Feb -3.9% -
Mar -7.0% -
Apr +8.7% -
May +0.7% -
Jun -0.9% -
Jul -2.1% -
Aug +1.9% -
Sep - -
Oct - -
Nov -7.6% -
Dec -4.3% -

How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.

Description: GRNY Fundstrat Granny Shots US

The Fundstrat Granny Shots US Large Cap ETF (GRNY) is an actively-managed exchange-traded fund listed on the NYSE that seeks to invest in U.S. large-capitalization equity securities. Under normal market conditions, it invests at least 80% of its net assets in large-cap U.S. companies, defined as those with a market capitalization greater than $10 billion. The fund is categorized as a Large Growth ETF and launched in late 2024. Unlike passive index-tracking ETFs, GRNY uses active management, allowing its portfolio managers to selectively pick securities based on their investment strategy rather than replicating a benchmark index.

Headlines to Watch Out For
  • Fund flows accelerate past $4 billion AUM milestone
  • Federal Reserve rate cuts boost large cap growth valuations
  • Fee competition pressures active ETF expense ratios lower
What is the price of GRNY shares?

As of September 27, 2026, the stock is trading at USD 28.32 with a total of 1,196,524 shares traded. Over the past week, the price has changed by +1.58%, over one month by +1.80%, over three months by +5.08% and over the past year by +15.11%.

Current recommended Stop Loss: 27.60 (which is 2.5% or 2.1 ATR below the current price).

Is GRNY a buy, sell or hold?

Fundstrat Granny Shots US has no consensus analysts rating.